Table 3.
Demographic characteristics of infants that completed the 24-month evaluation and infants lost to follow-up.
| Mullen at 24 months | Dead | Lost to follow-up | Cerebral palsy | Othera | Total | |
|---|---|---|---|---|---|---|
| Lactoferrin | ||||||
| n | 143 | 37 | 20 | 5 | 4 | 209 |
| Birth weight, g, mean (SD) | 1462 (323) | 978 (325) | 1572 (274) | 1118 (228) | 1655 (185) | 1382 (371) |
| Gestational age at birth, weeks, mean (SD) | 31.4 (2.4) | 28.2 (2.5) | 31.8 (2.8) | 27.8 (2.7) | 31.0 (3.3) | 30.8 (2.8) |
| Male sex, n (%) | 79 (55.2) | 19 (51.4) | 9 (45.0) | 3 (60.0) | 4 (100.0) | 114 (54.6) |
| SGA, n (%) | 37 (25.9) | 14 (37.8) | 5 (25.0) | 0 (0.0) | 1 (25.0) | 57 (27.3) |
| Placebo | ||||||
| n | 149 | 29 | 18 | 6 | 3 | 205 |
| Birth weight, g, mean (SD) | 1432 (309) | 947 (248) | 1661 (313) | 1214 (295) | 1475 (117) | 1378 (353) |
| Gestational age at birth, weeks, mean (SD) | 31.2 (2.8) | 27.6 (2.8) | 32.8 (3.1) | 29.8 (4.1) | 31.3 (1.5) | 30.8 (3.2) |
| Male sex, n (%) | 87 (58.4) | 12 (41.4) | 11 (61.1) | 3 (50.0) | 3 (100.0) | 116 (56.6) |
| SGA, n (%) | 46 (30.9) | 5 (17.2) | 6 (33.3) | 1 (16.7) | 1 (33.3) | 59 (28.8) |
Abbreviations: SD, standard deviation; SGA, small for gestational age
a
Other: Completed the 24-month follow up, but did not completed the Mullen test